TP53 mutation in newly diagnosed acute myeloid leukemia and myelodysplastic syndrome

OBJECTIVES: TP53 mutation is found frequently in therapy related acute myeloid leukemia (AML)/ myelodysplastic syndrome (MDS), AML and MDS patients with monosomy or complex karyotype. However, the prevalence and treatment outcome in TP53 mutated AML/MDS patients in Asian population are scarce. We th...

Descripción completa

Detalles Bibliográficos
Autores principales: Niparuck, Pimjai, Police, Pornnapa, Noikongdee, Phichchapha, Siriputtanapong, Kanchana, Limsuwanachot, Nittaya, Rerkamnuaychoke, Budsaba, Chuncharunee, Suporn, Siriboonpiputtana, Teerapong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557522/
https://www.ncbi.nlm.nih.gov/pubmed/34717674
http://dx.doi.org/10.1186/s13000-021-01162-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557522/
https://www.ncbi.nlm.nih.gov/pubmed/34717674
http://dx.doi.org/10.1186/s13000-021-01162-8

Ejemplares similares